Chong Kun Dang Pharmaceutical Corp.
Simbolis: 185750.KS
KSC
101200
KRWRinkos kaina šiandien
6.5327
P/E santykis
0.2409
PEG koeficientas
1.29T
MRK kapitalizacija
- 0.01%
DIV pajamingumas
Chong Kun Dang Pharmaceutical Corp. (185750-KS) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 977306.91 | 365065.3 | 155861.2 | 187332.6 | |||||||||||
balance-sheet.row.short-term-investments | 234574.58 | 145418.9 | 38444.3 | 55519.9 | |||||||||||
balance-sheet.row.net-receivables | 1166084.87 | 311468.6 | 287306.6 | 234703.7 | |||||||||||
balance-sheet.row.inventory | 1101639.04 | 261431.9 | 270081.5 | 224722.9 | |||||||||||
balance-sheet.row.other-current-assets | 9554.78 | 8606.1 | 365.5 | 20387.9 | |||||||||||
balance-sheet.row.total-current-assets | 3254585.6 | 946571.9 | 713614.8 | 667147.2 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 1263852.99 | 319787.1 | 310697.4 | 298909.7 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 176043.64 | 52527.1 | 26953 | 20805.5 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 176043.64 | 52527.1 | 26953 | 20805.5 | |||||||||||
balance-sheet.row.long-term-investments | 110109.3 | 67179.1 | 5565.5 | -22146.7 | |||||||||||
balance-sheet.row.tax-assets | 35440.27 | 14213.2 | 6208.6 | 2350.3 | |||||||||||
balance-sheet.row.other-non-current-assets | 186897.57 | 2150.1 | 61843.5 | 79634.1 | |||||||||||
balance-sheet.row.total-non-current-assets | 1772343.77 | 455856.6 | 411268 | 379552.9 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 5026929.37 | 1402428.4 | 1124882.8 | 1046700.1 | |||||||||||
balance-sheet.row.account-payables | 677227.23 | 183938.8 | 145436.3 | 129327.4 | |||||||||||
balance-sheet.row.short-term-debt | 615980.74 | 184767.4 | 124445.5 | 102091.4 | |||||||||||
balance-sheet.row.tax-payables | 130003.78 | 43938.2 | 29026.4 | 18701.1 | |||||||||||
balance-sheet.row.long-term-debt-total | 301223.13 | 30000 | 111292.6 | 134962.3 | |||||||||||
Deferred Revenue Non Current | 14490.66 | 1484.8 | 6438.3 | 5982 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 21900.45 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 286154.11 | 134996.6 | 98922.3 | 20691.5 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 395681.85 | 75327.4 | 129380.9 | 160660.6 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 31147.98 | 4996.5 | 1694.2 | 3470.5 | |||||||||||
balance-sheet.row.total-liab | 2153650.5 | 586793.3 | 503594 | 480890.4 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 125684.64 | 31421.2 | 29970.1 | 28565.2 | |||||||||||
balance-sheet.row.retained-earnings | 1554612.31 | 218102.4 | 376370.8 | 302106.6 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1404661.23 | 350829.8 | 276706.4 | 250156.9 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | -210144.4 | 215341.1 | -60654.3 | -14818.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 2874813.78 | 815694.5 | 622393.1 | 566010 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 5026929.37 | 1402428.4 | 1124882.8 | 1046700.1 | |||||||||||
balance-sheet.row.minority-interest | -1534.92 | -59.3 | -1104.3 | -200.3 | |||||||||||
balance-sheet.row.total-equity | 2873278.86 | 815635.2 | 621288.8 | 565809.6 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 5026929.37 | - | - | - | |||||||||||
Total Investments | 344683.88 | 212598 | 44009.8 | 33373.2 | |||||||||||
balance-sheet.row.total-debt | 922200.38 | 219763.9 | 235738.1 | 237053.8 | |||||||||||
balance-sheet.row.net-debt | 179468.05 | 117.5 | 118321.2 | 105241.1 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 213740.93 | 212521.2 | 79977.8 | 42356.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 37007.96 | 36942.2 | 33597.7 | 27481.9 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 29681.84 | 29681.8 | -77299.3 | -71568.7 | |||||||||||
cash-flows.row.account-receivables | -29559.69 | -29559.7 | -51435.9 | -6926 | |||||||||||
cash-flows.row.inventory | -5980.26 | -5980.3 | -54466.2 | -53770.6 | |||||||||||
cash-flows.row.account-payables | 38583.78 | 38583.8 | 15824.5 | -15597.8 | |||||||||||
cash-flows.row.other-working-capital | 26638.01 | 26638 | 12778.2 | 4725.7 | |||||||||||
cash-flows.row.other-non-cash-items | 37729.17 | 39014.7 | 31458.4 | 14634.2 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 318159.91 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -68806.05 | -68806 | -53064.7 | -51844.4 | |||||||||||
cash-flows.row.acquisitions-net | 20636.77 | 451.6 | 142.1 | -3448.7 | |||||||||||
cash-flows.row.purchases-of-investments | -192468.23 | -192468.2 | -57181.1 | -61266.4 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 89470.04 | 89470 | 44375.6 | 21934.7 | |||||||||||
cash-flows.row.other-investing-activites | -20145.43 | 39.8 | 347.8 | 3815.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -171312.9 | -171312.9 | -65380.3 | -90809.3 | |||||||||||
cash-flows.row.debt-repayment | -44714.6 | -22714.6 | -0.3 | -896.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | -3335.3 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | -6024.99 | -6025 | -1888.4 | -1935.3 | |||||||||||
cash-flows.row.dividends-paid | 0 | -11608.5 | -11238.8 | -10808.3 | |||||||||||
cash-flows.row.other-financing-activites | 18648.14 | -16.5 | -3212.4 | 98778.7 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -43699.98 | -43700 | -16339.8 | 85138.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -917.57 | -917.6 | -410.1 | 920.1 | |||||||||||
cash-flows.row.net-change-in-cash | 102229.45 | 102229.4 | -14395.8 | 8153.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 742732.33 | 219646.3 | 117416.9 | 131812.7 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 640502.88 | 117416.9 | 131812.7 | 123659.1 | |||||||||||
cash-flows.row.operating-cash-flow | 318159.91 | 318159.9 | 67734.5 | 12903.9 | |||||||||||
cash-flows.row.capital-expenditure | -68806.05 | -68806 | -53064.7 | -51844.4 | |||||||||||
cash-flows.row.free-cash-flow | 249353.86 | 249353.9 | 14669.8 | -38940.5 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1657673.31 | 1669404.4 | 1488344.7 | 1343559.4 | |||||||||||
income-statement-row.row.cost-of-revenue | 779200.12 | 1014059.9 | 945705.3 | 847741.1 | |||||||||||
income-statement-row.row.gross-profit | 878473.19 | 655344.5 | 542639.4 | 495818.3 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 104406.15 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 199875.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 80977.59 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | -716317.4 | -11694.4 | 139957.4 | 135069 | |||||||||||
income-statement-row.row.operating-expenses | 249710.32 | 408657.6 | 432733.3 | 401059.6 | |||||||||||
income-statement-row.row.cost-and-expenses | 1222350.41 | 1422717.5 | 1378438.7 | 1248800.7 | |||||||||||
income-statement-row.row.interest-income | 4775.61 | 5789.3 | 2139 | 716.2 | |||||||||||
income-statement-row.row.interest-expense | 7001.12 | 9271 | 6846.9 | 4029.9 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 80977.59 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 1.88 | -5283.9 | -12741 | -14164.8 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | -716317.4 | -11694.4 | 139957.4 | 135069 | |||||||||||
income-statement-row.row.total-operating-expenses | 1.88 | -5283.9 | -12741 | -14164.8 | |||||||||||
income-statement-row.row.interest-expense | 7001.12 | 9271 | 6846.9 | 4029.9 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 202519.12 | 36942.2 | 34919.3 | 18187.3 | |||||||||||
income-statement-row.row.ebitda-caps | 444402.06 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 241882.93 | 246686.9 | 109906.1 | 94758.7 | |||||||||||
income-statement-row.row.income-before-tax | 241884.82 | 241403 | 97165.1 | 80593.9 | |||||||||||
income-statement-row.row.income-tax-expense | 39271.89 | 27995.7 | 17187.3 | 38237.4 | |||||||||||
income-statement-row.row.net-income | 201766.15 | 212521.2 | 80953.4 | 42720.4 |
Dažnai užduodami klausimai
Kas yra Chong Kun Dang Pharmaceutical Corp. (185750.KS) bendras turtas?
Chong Kun Dang Pharmaceutical Corp. (185750.KS) bendras turtas yra 1402428435512.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 858061047502.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.530.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 19599.181.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.122.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.146.
Kas yra Chong Kun Dang Pharmaceutical Corp. (185750.KS) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 212521171440.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 219763880100.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 408657610015.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 219646348416.000.